Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen patiënten verder geëvalueerd te worden?

Daan J. Reesink; Elisabeth E. Fransen van de Putte; Erik Vegt; Jeroen de Jong; Erik van Werkhoven; Laura S. Mertens; Axel Bex; Henk G. van der Poel; Bas W G van Rhijn; Simon Horenblas; Richard P. Meijer

doi:10.1007/s13629-016-0124-5

Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen patiënten verder geëvalueerd te worden?

Translated title of the contribution: Clinical relevance of incidental prostatic lesions on FDG-PET/CT Scan: Should patients receive further evaluation?

Daan J. Reesink
, Elisabeth E. Fransen van de Putte
, Erik Vegt
, Jeroen de Jong
, Erik van Werkhoven
, Laura S. Mertens
, Axel Bex
, Henk G. van der Poel
, Bas W G van Rhijn
, Simon Horenblas
, Richard P. Meijer^*

^*Corresponding author for this work

Department of Urological Oncology

Research output: Contribution to journal › Article › Academic › peer-review

2 Downloads (Pure)

Abstract

The purpose of this study was to determine the clinical relevance of incidental prostatic uptake (IPU) on FDG-PET/CT. We analyzed 108 male bladder cancer patients who underwent FDG-PET/CT imaging, and subsequently a cystoprostatectomy, from 2009–2014. IPU had a poor diagnostic accuracy for detecting prostate cancer. Classification of IPU as ‘suspect’ or ‘non-suspect’ by nuclear medicine physician did not improve diagnostic results. Physicians should therefore be cautious to apply invasive diagnostic methods to detect prostate cancer in case of IPU on FDG-PET/CT.

Translated title of the contribution	Clinical relevance of incidental prostatic lesions on FDG-PET/CT Scan: Should patients receive further evaluation?
Original language	Dutch
Pages (from-to)	80-87
Number of pages	8
Journal	Tijdschrift voor Urologie
Volume	6
Issue number	5
DOIs	https://doi.org/10.1007/s13629-016-0124-5
Publication status	Published - 1 Aug 2016

Keywords

18FDG
computed tomography (CT)
fluorodeoxyglucose F18
positron emission tomography (PET)
prostate cancer

Access to Document

10.1007/s13629-016-0124-5

5Final published version, 3.65 MBLicence: Taverne

Cite this

Reesink, D. J., Fransen van de Putte, E. E., Vegt, E., de Jong, J., van Werkhoven, E., Mertens, L. S., Bex, A., van der Poel, H. G., van Rhijn, B. W. G., Horenblas, S., & Meijer, R. P. (2016). Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen patiënten verder geëvalueerd te worden? Tijdschrift voor Urologie, 6(5), 80-87. https://doi.org/10.1007/s13629-016-0124-5

@article{7a7b99d6dc3744378ae876a351d2f4e0,

title = "Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen pati{\"e}nten verder ge{\"e}valueerd te worden?",

abstract = "The purpose of this study was to determine the clinical relevance of incidental prostatic uptake (IPU) on FDG-PET/CT. We analyzed 108 male bladder cancer patients who underwent FDG-PET/CT imaging, and subsequently a cystoprostatectomy, from 2009{\textendash}2014. IPU had a poor diagnostic accuracy for detecting prostate cancer. Classification of IPU as {\textquoteleft}suspect{\textquoteright} or {\textquoteleft}non-suspect{\textquoteright} by nuclear medicine physician did not improve diagnostic results. Physicians should therefore be cautious to apply invasive diagnostic methods to detect prostate cancer in case of IPU on FDG-PET/CT.",

keywords = "18FDG, computed tomography (CT), fluorodeoxyglucose F18, positron emission tomography (PET), prostate cancer",

author = "Reesink, \{Daan J.\} and \{Fransen van de Putte\}, \{Elisabeth E.\} and Erik Vegt and \{de Jong\}, Jeroen and \{van Werkhoven\}, Erik and Mertens, \{Laura S.\} and Axel Bex and \{van der Poel\}, \{Henk G.\} and \{van Rhijn\}, \{Bas W G\} and Simon Horenblas and Meijer, \{Richard P.\}",

year = "2016",

month = aug,

day = "1",

doi = "10.1007/s13629-016-0124-5",

language = "Dutch",

volume = "6",

pages = "80--87",

journal = "Tijdschrift voor Urologie",

issn = "2211-3037",

publisher = "Springer Science + Business Media",

number = "5",

}

Reesink, DJ, Fransen van de Putte, EE, Vegt, E, de Jong, J, van Werkhoven, E, Mertens, LS, Bex, A, van der Poel, HG, van Rhijn, BWG, Horenblas, S & Meijer, RP 2016, 'Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen patiënten verder geëvalueerd te worden?', Tijdschrift voor Urologie, vol. 6, no. 5, pp. 80-87. https://doi.org/10.1007/s13629-016-0124-5

TY - JOUR

T1 - Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan

T2 - Dienen patiënten verder geëvalueerd te worden?

AU - Reesink, Daan J.

AU - Fransen van de Putte, Elisabeth E.

AU - Vegt, Erik

AU - de Jong, Jeroen

AU - van Werkhoven, Erik

AU - Mertens, Laura S.

AU - Bex, Axel

AU - van der Poel, Henk G.

AU - van Rhijn, Bas W G

AU - Horenblas, Simon

AU - Meijer, Richard P.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The purpose of this study was to determine the clinical relevance of incidental prostatic uptake (IPU) on FDG-PET/CT. We analyzed 108 male bladder cancer patients who underwent FDG-PET/CT imaging, and subsequently a cystoprostatectomy, from 2009–2014. IPU had a poor diagnostic accuracy for detecting prostate cancer. Classification of IPU as ‘suspect’ or ‘non-suspect’ by nuclear medicine physician did not improve diagnostic results. Physicians should therefore be cautious to apply invasive diagnostic methods to detect prostate cancer in case of IPU on FDG-PET/CT.

AB - The purpose of this study was to determine the clinical relevance of incidental prostatic uptake (IPU) on FDG-PET/CT. We analyzed 108 male bladder cancer patients who underwent FDG-PET/CT imaging, and subsequently a cystoprostatectomy, from 2009–2014. IPU had a poor diagnostic accuracy for detecting prostate cancer. Classification of IPU as ‘suspect’ or ‘non-suspect’ by nuclear medicine physician did not improve diagnostic results. Physicians should therefore be cautious to apply invasive diagnostic methods to detect prostate cancer in case of IPU on FDG-PET/CT.

KW - 18FDG

KW - computed tomography (CT)

KW - fluorodeoxyglucose F18

KW - positron emission tomography (PET)

KW - prostate cancer

UR - https://www.scopus.com/pages/publications/84982106663

U2 - 10.1007/s13629-016-0124-5

DO - 10.1007/s13629-016-0124-5

M3 - Article

AN - SCOPUS:84982106663

SN - 2211-3037

VL - 6

SP - 80

EP - 87

JO - Tijdschrift voor Urologie

JF - Tijdschrift voor Urologie

IS - 5

ER -

Klinische relevantie van incidentele prostaatlaesies op een FDG-PET/CT-scan: Dienen patiënten verder geëvalueerd te worden?

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this